Drugs / Purified Vero Rabies Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01877395 | Jun 2013 → May 2014 | rabies | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified Vero Rabies Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01877395 ↗ |
| Known as | VRVg | “Participants will receive the Purified Vero Rabies Vaccine (VRVg)” NCT01877395 ↗ |
| Modality | Vaccine | “five vaccine injections” NCT01877395 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01877395 ↗ |